Selegiline and Dopamine Interaction

Drug interaction information between Selegiline and Dopamine.

Selegiline and Dopamine have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Selegiline and Dopamine. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Selegiline

Selective MAO-B Inhibitor

Drug B

Dopamine

Inotropic / Vasopressor

How They Interact

This drug prevents the body from breaking down dopamine, which makes the dopamine much more powerful. This can lead to a severe and rapid increase in blood pressure.

FDA Label Information

Examples: isocarboxazid, phenelzine, tranylcypromine, rasagiline, selegiline, linezolid.

Frequently Asked Questions

What SPL severity band is on file for Selegiline + Dopamine?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Dopamine has 28 labeled pairs on file vs Selegiline's 9. In the minor band specifically: Selegiline has 3 (also Meperidine, Methylphenidate); Dopamine has 23 (also Amitriptyline, Doxepin, Linezolid, Nortriptyline).

What mechanism field is on file for Selegiline and Dopamine?

This drug prevents the body from breaking down dopamine, which makes the dopamine much more powerful. This can lead to a severe and rapid increase in blood pressure.

Dopamine's labeled portfolio outnumbers Selegiline

SPL source-record counts only. This page's band is minor · classes on file: Selegiline (Selective MAO-B Inhibitor); Dopamine (Inotropic / Vasopressor).

Selegiline

0 major · 6 moderate · 3 minor · 9 total

Dopamine

0 major · 5 moderate · 23 minor · 28 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.